Episode notes
In this podcast, Alejandro Forner summarised and commented some selected abstracts at the EASL Liver Cancer Summit 2022.
The following abstracts will be discussed:
1. Regorafenib in patients with unresectable hepatocellular carcinoma in routine clinical practice: Exploratory analysis of safety and overall survival in the prospective, observational REFINE study. Finn R, et al. Liver Cancer Summit 2022 OS-55
2. Efficacy of combination therapy with lenvatinib, programmed cell death 1 inhibitors and transarterial therapy: a propensity score-matching cohort study. Wei Lu, et al. Liver Cancer Summit 2022 PO-119
... Read more